US Bancorp DE Buys 4,656 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

US Bancorp DE boosted its stake in Astrana Health, Inc. (NASDAQ:ASTHFree Report) by 3,880.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,776 shares of the company’s stock after purchasing an additional 4,656 shares during the period. US Bancorp DE’s holdings in Astrana Health were worth $151,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Janus Henderson Group PLC acquired a new stake in Astrana Health in the third quarter valued at $1,164,000. Royce & Associates LP acquired a new stake in Astrana Health in the third quarter valued at $6,661,000. Amalgamated Bank acquired a new stake in Astrana Health in the third quarter valued at $713,000. Principal Financial Group Inc. acquired a new stake in Astrana Health in the third quarter valued at $13,383,000. Finally, Loomis Sayles & Co. L P acquired a new stake in Astrana Health in the third quarter valued at $30,251,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ASTH has been the subject of a number of recent research reports. Bank of America decreased their price objective on Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a report on Tuesday, March 4th. Robert W. Baird decreased their price target on Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a report on Monday, March 3rd. Macquarie upgraded Astrana Health to a “hold” rating in a report on Monday, December 16th. Truist Financial decreased their price target on Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a report on Monday, January 13th. Finally, Stifel Nicolaus decreased their price target on Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Astrana Health presently has an average rating of “Moderate Buy” and an average price target of $56.83.

Check Out Our Latest Report on ASTH

Astrana Health Price Performance

ASTH stock opened at $29.34 on Friday. The stock has a market capitalization of $1.65 billion, a PE ratio of 22.57, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. The company’s 50-day moving average is $33.96 and its 200-day moving average is $43.10. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. Astrana Health, Inc. has a 1 year low of $23.12 and a 1 year high of $63.20.

Astrana Health (NASDAQ:ASTHGet Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). The company had revenue of $665.21 million for the quarter, compared to the consensus estimate of $617.24 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. Equities research analysts expect that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

About Astrana Health

(Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Stories

Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. (NASDAQ:ASTHFree Report).

Institutional Ownership by Quarter for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.